We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$292M
AUM Growth
+$16.8M
Cap. Flow
-$7.89M
Cap. Flow %
-2.7%
Top 10 Hldgs %
29.91%
Holding
120
New
8
Increased
27
Reduced
29
Closed
13

Top Buys

Rank Stock Value
1
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$12.2M
2
ARWR icon
Arrowhead Research
ARWR
+$3.01M
3
BIIB icon
Biogen
BIIB
+$2.76M
4
GILD icon
Gilead Sciences
GILD
+$1.62M
5
BIDU icon
Baidu
BIDU
+$1.52M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.53M
2
CLDX icon
Celldex Therapeutics
CLDX
+$6.14M
3
YHOO
Yahoo Inc
YHOO
+$5.12M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.85M
5
NDLS icon
Noodles & Co
NDLS
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 22.95%
2 Energy 16.91%
3 Communication Services 13.82%
4 Industrials 9.86%
5 Consumer Discretionary 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RH icon
1
RH
RH
$2.83B
$21.8M 7.46%
323,733
+15,400
+5% +$1.06M
SGMO
2
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14.7M 5.04%
+1,059,000
New +$12.2M
AAPL icon
3
Apple
AAPL
$4.67T
$9.4M 3.22%
469,280
+69,160
+17% +$1.31M
EPD icon
4
Enterprise Products Partners
EPD
$84.3B
$6.67M 2.28%
201,210
+1,150
+0.6% +$35.8K
RTX icon
5
RTX Corp
RTX
$285B
$6.45M 2.21%
90,112
-88
-0.1% -$6K
BX icon
6
Blackstone
BX
$107B
$5.89M 2.02%
190,461
-790
-0.4% -$21.5K
APA icon
7
APA Corp
APA
$14.9B
$5.78M 1.98%
67,238
+875
+1% +$77.9K
PFE icon
8
Pfizer
PFE
$159B
$5.76M 1.97%
198,146
+4,954
+3% +$144K
MCK icon
9
McKesson
MCK
$104B
$5.56M 1.9%
34,445
+325
+1% +$49.9K
UNP icon
10
Union Pacific
UNP
$183B
$5.35M 1.83%
63,660
– –
IBM icon
11
IBM
IBM
$222B
$5.11M 1.75%
28,475
-262
-0.9% -$45.2K
LYB icon
12
LyondellBasell Industries
LYB
$20.6B
$5.1M 1.75%
63,495
+1,000
+2% +$76.6K
FWONA icon
13
Liberty Media Series A
FWONA
$23.4B
$5.08M 1.74%
195,359
+3,631
+2% +$96.4K
CEO
14
DELISTED
CNOOC Limited
CEO
$4.98M 1.71%
26,544
+37
+0.1% +$7.36K
EOG icon
15
EOG Resources
EOG
$75.2B
$4.9M 1.68%
58,364
-4,600
-7% -$394K
V icon
16
Visa
V
$712B
$4.9M 1.68%
87,980
-300
-0.3% -$15.1K
PAA icon
17
Plains All American Pipeline
PAA
$18B
$4.9M 1.68%
94,570
-200
-0.2% -$10.2K
ETN icon
18
Eaton
ETN
$156B
$4.84M 1.66%
63,590
+115
+0.2% +$8.18K
PARA
19
DELISTED
Paramount Global Class B
PARA
$4.8M 1.64%
75,342
+115
+0.2% +$6.76K
VOD icon
20
Vodafone
VOD
$37.1B
$4.61M 1.58%
115,102
-441
-0.4% -$16.6K
C icon
21
Citigroup
C
$223B
$4.48M 1.53%
85,982
+1,325
+2% +$67.1K
DHR icon
22
Danaher
DHR
$152B
$4.45M 1.52%
85,765
+543
+0.6% +$26.7K
XOM icon
23
ExxonMobil
XOM
$644B
$4.38M 1.5%
43,247
– –
DTV
24
DELISTED
DIRECTV COM STK (DE)
DTV
$4.34M 1.49%
62,845
+375
+0.6% +$24K
LBTYK icon
25
Liberty Global Class C
LBTYK
$3.56B
$4.29M 1.47%
125,872
+1,681
+1% +$52.4K
1
2 3 4 5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Private Capital Advisors held 120 positions worth $292M, up 6.1% from $275M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Private Capital Advisors's Q4 2013 filing shows 8 new, 27 increased, 29 reduced and 13 closed positions. Its largest new stake was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M. The largest sale was BioMarin Pharmaceuticals, an estimated $6.53M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • Private Capital Advisors's largest Q4 2013 buy was SANGAMO THERAPEUTICS INC: 1,059,000 shares worth $14.7M.
  • Private Capital Advisors added most to Biogen in Q4 2013, an estimated $2.76M increase.
  • Private Capital Advisors's biggest Q4 2013 reduction was Alphabet (Google) Class C, cutting an estimated $4.85M.
  • Private Capital Advisors fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $6.53M.
  • Private Capital Advisors's ten largest holdings make up 30% of its $292M portfolio in Q4 2013.
  • Private Capital Advisors opened 8 new positions and closed 13 in Q4 2013.
  • Private Capital Advisors's portfolio value rose 6.1% quarter-over-quarter to $292M.

Based on Private Capital Advisors's 13F filing for Q4 2013, filed 31 Jan 2014.